The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Elevated plasma low-density lipoprotein cholesterol (LDL-C) is the main risk factor for atherosclerotic cardiovascular disease (ASCVD). Statins are the drugs of choice for decreasing LDL-C and are used for the prevention and management of ASCVD. Guidelines recommend that subjects with hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamialahmadi, Tannaz, Baratzadeh, Fatemeh, Reiner, Željko, Simental-Mendía, Luis E., Xu, Suowen, Susekov, Andrey V., Santos, Raul D., Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437664/
https://www.ncbi.nlm.nih.gov/pubmed/34526854
http://dx.doi.org/10.1155/2021/9661752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437664/
https://www.ncbi.nlm.nih.gov/pubmed/34526854
http://dx.doi.org/10.1155/2021/9661752

Ejemplares similares